Back to top
more

Aveanna Healthcare (AVAH)

(Real Time Quote from BATS)

$5.70 USD

5.70
30,103

+0.13 (2.33%)

Updated Nov 18, 2024 11:32 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (152 out of 250)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

MultiPlan Stock Falls Even After NRHA Rural Healthcare Deal

by Zacks Equity Research

MPLN and NRHA team up to empower rural healthcare providers with innovative technology and data-driven solutions, improving access, quality and affordability.

Tactile Medical Stock Rises After Positive Flexitouch Trial Results

by Zacks Equity Research

TCMD announces a new study evaluating Flexitouch. The study reveals significant improvements in health-related quality of life and clinical outcomes.

Fast-paced Momentum Stock Aveanna (AVAH) Is Still Trading at a Bargain

by Zacks Equity Research

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Aveanna (AVAH) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

ICU Medical's Stock Rises Despite Bivona Tracheostomy Tube Recall

by Zacks Equity Research

ICUI's Smiths Medical recalls Bivona tracheostomy tubes over a defect that may lead to serious health risks, including airway loss and death.

Trinity Biotech's Stock Rises After Acquisition of Metabolomics

by Zacks Equity Research

TRIB acquires Metabolomics Diagnostics, expanding its platform with cutting-edge tech to enhance diagnostics in maternal health and diabetes management.

Cardinal Health Stock Likely to Gain From the Acquisition of ION

by Zacks Equity Research

CAH is set to acquire Oncology Network for $1.115 billion, expanding its oncology offerings while supporting community-based cancer care across 10 states.

ANGO Initiates RECOVER-AV Trial for AlphaVac F1885 in Europe

by Zacks Equity Research

AngioDynamics' RECOVER-AV trial evaluates the AlphaVac F1885 System's safety and efficacy in treating acute pulmonary embolism in Europe.

Here's Why You Should Hold Cencora Stock in Your Portfolio for Now

by Zacks Equity Research

COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

GE HealthCare Shares Rise After AI-Powered Venue Sprint's Launch

by Zacks Equity Research

GEHC introduces Venue Sprint, a portable AI-enabled ultrasound device offering wireless probes, real-time insights and advanced clinical tools for improved care.

Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Aveanna Healthcare (AVAH) and AxoGen (AXGN) have performed compared to their sector so far this year.

BD Stock Rises as Neopak XtraFlow Syringe Expands in Biologics

by Zacks Equity Research

BDX launches the Neopak XtraFlow Glass Prefillable Syringe, enhancing drug delivery for biologics and expanding capacity with new high-volume production lines.

Merit Medical Stock Falls Despite Positive WRAPSODY Trial Results

by Zacks Equity Research

MMSI announces 6-month results from its WRAPSODY WAVE trial, showing superior efficacy in extending AV fistula patency for dialysis patients.

Tactile Medical's Shares Rise After PDAC Approval for Nimbl

by Zacks Equity Research

TCMD's Nimbl pneumatic compression system gets CMS PDAC approval and is set to be launched in the United States soon, following FDA clearance for treating lymphedema.

Masimo Stock Likely to Rise With Qualcomm Wear OS Partnership

by Zacks Equity Research

MASI Collaborates with Qualcomm to develop a reference platform for Wear OS smartwatches, combining biosensing tech and Snapdragon chips to enhance performance and connectivity.

iRhythm's Zio ECG System Gets Approval in Japan, Stock Falls

by Zacks Equity Research

IRTC's Zio ECG monitoring system gets approval in Japan, marking a significant step in revolutionizing arrhythmia diagnostics with AI-powered technology.

PacBio Stock Drops After Singapore Collaboration for HiFi Sequencing

by Zacks Equity Research

PACB's HiFi sequencing powers the HiFi Consortium's global effort to enhance the diagnosis and treatment of subfertility and recurrent pregnancy loss.

PacBio's Stock Up on Munster Deal for Male Infertility Research

by Zacks Equity Research

PACB collaborates with the University Hospital of Munster, using Revio HiFi sequencing to advance research on male infertility and rare diseases in Germany and globally.

Femasys Stock Rises After FDA Clearance for FemChec Diagnostic Device

by Zacks Equity Research

FEMY gains after FDA clearance for FemChec, a fallopian tube diagnostic tool designed for safe, in-office use, enhancing non-surgical birth control procedures.

Why Fast-paced Mover Aveanna (AVAH) Is a Great Choice for Value Investors

by Zacks Equity Research

Aveanna (AVAH) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Are Medical Stocks Lagging Basilea Pharmaceutica (BPMUF) This Year?

by Zacks Equity Research

Here is how Basilea Pharmaceutica AG (BPMUF) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.

Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Indrajit Bandyopadhyay headshot

Aveanna Stock Rallies 110% in 3 Months: Is It Still Worth Buying?

by Indrajit Bandyopadhyay

AVAH stock has the potential to continue its uptrend on the back of a better payer rate environment and its focus on high-paying customers.

Are You Looking for a Top Momentum Pick? Why Aveanna Healthcare (AVAH) is a Great Choice

by Zacks Equity Research

Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Despite Fast-paced Momentum, Aveanna (AVAH) Is Still a Bargain Stock

by Zacks Equity Research

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Aveanna (AVAH) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Is Basilea Pharmaceutica (BPMUF) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Basilea Pharmaceutica AG (BPMUF) and Aveanna Healthcare (AVAH) have performed compared to their sector so far this year.